Skip to content

Drug interactions

Bosutinib + Ondansetron

Severity: Moderate

Bosutinib and Ondansetron: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosutinib inhibits P-glycoprotein and may raise ondansetron exposure. Bosutinib can also prolong the QT interval, so combined use may increase arrhythmia risk.

What this interaction means in plain words

Bosutinib and Ondansetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosutinib belongs to Oncology; Ondansetron belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

P-glycoprotein inhibition plus additive QT prolongation.

What to do

Obtain a baseline ECG and correct potassium and magnesium. Monitor the ECG during combined use, or choose an antiemetic with less QT effect.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosutinib and Ondansetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosutinib with Ondansetron?

MediHelp rates the interaction as moderate. Bosutinib and Ondansetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Bosutinib inhibits P-glycoprotein and may raise ondansetron exposure. Bosutinib can also prolong the QT interval, so combined use may increase arrhythmia risk.

How serious is the interaction between Bosutinib and Ondansetron?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and correct potassium and magnesium. Monitor the ECG during combined use, or choose an antiemetic with less QT effect.

What other medicines interact with Ondansetron?

MediHelp also lists interactions of Ondansetron with, for example, Apomorphine, Thioridazine, Vandetanib. The full list is on the Ondansetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in